Interventional Neurology: Mechanical Thrombectomy Devices
Mechanical thrombectomy (MT) is an emergency surgical technique used in eligible patients experiencing acute ischemic stroke (AIS) to remove a blood clot in the brain. In 2021, the combined global market for neuroendovascular MT devices was estimated at approximately $706m. Market drivers include an expanding elderly population with an associated rising risk of AIS, an underpenetrated market, increasing adoption of next-generation MT devices that demonstrate improved outcomes, and broader availability at a wider range of care facilities. Limiters of this market include limited access to specialty stroke centers offering MT, limited patient eligibility, and financial obstacles (particularly in low- and middle-income countries). This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global markets for MT devices; these include stent retrievers and aspiration catheters. Countries covered by this analysis include the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world (RoW) markets. The forecast range for this report is 2021–26.
Related Medtech Insight articles:
- September 21, 2021 - Boston Scientific Acquires Devoro Medical To Add Thrombectomy Tech
- January 13, 2022 - Cardio Industry Puts Weight Behind UK Call For National CVD Strategy
- January 13, 2022 - JPM 2022: Abiomed, Penumbra, Renalityx
- Subscribe to Medtech Insight to view these articles and more!